Loading...
Loading...
India's cefuroxime imports from SRI LANKA total $10 across 1 shipments from 1 foreign suppliers. SANDS ACTIVE PVT LTD leads with $10 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include INDIAN ANALYTICAL LABORATORIES. This corridor reflects India's pharmaceutical import demand for cefuroxime — a concentrated sourcing relationship with select suppliers from SRI LANKA.

SANDS ACTIVE PVT LTD is the leading Cefuroxime supplier from SRI LANKA to India, with import value of $10 across 1 shipments. The top 5 suppliers — SANDS ACTIVE PVT LTD — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | SANDS ACTIVE PVT LTD | $10 | 1 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | INDIAN ANALYTICAL LABORATORIES | $10 | 1 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Cefuroxime suppliers from SRI LANKA to India include SANDS ACTIVE PVT LTD. The leading supplier is SANDS ACTIVE PVT LTD with import value of $10 USD across 1 shipments. India imported Cefuroxime worth $10 USD from SRI LANKA in total across 1 shipments.
India imported Cefuroxime worth $10 USD from SRI LANKA across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Cefuroxime sourced from SRI LANKA include INDIAN ANALYTICAL LABORATORIES. The largest buyer is INDIAN ANALYTICAL LABORATORIES with $10 in imports across 1 shipments.
The total value of Cefuroxime imports from SRI LANKA to India is $10 USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists